NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences climbed 13.1 percent in afternoon trade on the Nasdaq after the firm said that it had taken the first order for its HeliScope next-generation single molecule sequencing platform.
 
A company spokesperson declined to name the customer who placed the order.
 
Shares of Helicos were trading at $13.03 this afternoon.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.